{'fraction_non_alphanumeric': 0.02843016069221261, 'fraction_numerical': 0.007416563658838072, 'mean_word_length': 5.377952755905512, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Metabolism of the radioprotective agent triammonium 2-dithiocarbamyl-3-dithiocarbonylthiopropanoate in the mouse.

To determine whether one or both of the sulfur-containing functions of the dithiocarbamate trithiocarbonate (I) of cysteine is responsible for its radioprotective ability, 35S-I was synthesized and its metabolism was studied in mice. The major metabolite was the dithiocarbamate of cystine, which was found in the liver, kidney, and spleen. The protein-bound component was also found in these tissues. Other metabolites found were intact I and possibly cystine in the liver and sulfate in the kidney and spleen. 35S-I was rapidly eliminated, and radioactive compounds which appeared in the urine included the dithiocarbamate, unchanged I, sulfate, and an unidentified substance in small amount.